Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells

Retraction in: /ijo/41/5/1887

  • Authors:
    • Abraham Amsterdam
    • Elias Shezen
    • Calanit Raanan
    • Letizia Schreiber
    • Yasmin Slilat
    • Yakov Fabrikant
    • Ehud Melzer
    • Rony Seger
  • View Affiliations

  • Published online on: November 22, 2011     https://doi.org/10.3892/ijo.2011.1268
  • Pages: 782-788
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We have used human specimens and antibodies to pERK1/2 to detect early development of colon cancer, using indirect immunocytochemistry. Two distinct sites were stained; one at the tip of the colon villi and the other in the stromal tissue, associated with the colon tissue. These foci represent early stages of colon cancer initiation, as established by enhanced KRAS, and lack of p53 staining. It should be noted, however, that the enhanced KRAS coincides with the initiation of tumor growth revealed by pERK1/2 only in the tip of the colon villi but not in the stromal initiation site of the colon tumors. Interestingly, foci of pERK1/2 staining were also detected within 50% of stromal tissue and tips of colon villi, that were classified as normal tissues, distal from the malignant one according to general morphology. The staining of pERK1/2 at the stromal foci of this apparently non-malignant tissue appeared as aggregates at the perinuclear region, while at the colon epithelium, it appeared at the cell nuclei. At low-grade of colon cancer, that was still free of induced mutated p53, staining of pERK1/2 was prominent at the cell nuclei both at the stroma tissue and the tip of the colon villi. In intermediate stage, that exhibited a significant p53 staining, only a fraction of p53-free tumor cells was labeled with pERK1/2 antibody, while in high-grade tumors, all cells of tumors were labeled with antibodies to p53, but not with pERK1/2. We also found that the cytoplasm of low-grade tumors was positive for epiregulin, while this labeling decreased in high-grade tumors. Interestingly, we found that the tumors initiating from the stroma demonstrated poor structural differentiation, while the tumors initiating from the epithelial cells of the colon demonstrated high structural differentiation. It is concluded that pERK1/2 is a sensitive early marker of colon cancer, which disappears at later stages of cancer development. Moreover, pERK1/2 staining can distinguish between tumor cells originated from the tip of the colon villi and those originated in the stroma, associated with the colon tissue, and thus can assist in selecting the appropriate therapy.

Retracted

Related Articles

Journal Cover

March 2012
Volume 40 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Amsterdam A, Shezen E, Raanan C, Schreiber L, Slilat Y, Fabrikant Y, Melzer E and Seger R: Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells Retraction in /ijo/41/5/1887. Int J Oncol 40: 782-788, 2012
APA
Amsterdam, A., Shezen, E., Raanan, C., Schreiber, L., Slilat, Y., Fabrikant, Y. ... Seger, R. (2012). Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells Retraction in /ijo/41/5/1887. International Journal of Oncology, 40, 782-788. https://doi.org/10.3892/ijo.2011.1268
MLA
Amsterdam, A., Shezen, E., Raanan, C., Schreiber, L., Slilat, Y., Fabrikant, Y., Melzer, E., Seger, R."Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells Retraction in /ijo/41/5/1887". International Journal of Oncology 40.3 (2012): 782-788.
Chicago
Amsterdam, A., Shezen, E., Raanan, C., Schreiber, L., Slilat, Y., Fabrikant, Y., Melzer, E., Seger, R."Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells Retraction in /ijo/41/5/1887". International Journal of Oncology 40, no. 3 (2012): 782-788. https://doi.org/10.3892/ijo.2011.1268